United States· US:13925-163_ccdbd16c-75e3-45f0-9e35-348ba321201b
Lidocaine Hydrochloride and Hydrocortisone Acetate
A medicinal product containing lidocaine hydrochloride; hydrocortisone acetate, registered in United States by Seton Pharmaceuticals.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LIDOCAINE HYDROCHLORIDE; HYDROCORTISONE ACETATE
- Manufacturer
- Seton Pharmaceuticals
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11139251632020 TUBE in 1 KIT (13925-163-20) / 7 g in 1 TUBE (13925-163-07)
- ndc1113925-163-20
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lidocaine hydrochloride; hydrocortisone acetate in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGermoloids HC sprayBayer Plc
- FinlandXyloproctAstraZeneca Oy
- IcelandXyloproctAspen Pharma Trading Limited
- SwedenXyloproct RektalsalvaAspen Pharma Trading Limited
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Perinal, Xyloproct
- Greece · Forproct
- Hungary · Hydrocortison Richter
- Iceland · Xyloproct
- Italy · Emorril, Lidocaina Cloridrato E Idrocortisone Acetato Marco Viti
- Lithuania · Hydrocortison Richter
- Latvia · Hydrocortison Richter
- Malta · Lidoproctene
- Norway · Xyloproct
- Sweden · Xyloproct
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b059fbcd-3277-4435-be81-d9ca2aeca9e6 GET /v1/drugs/b059fbcd-3277-4435-be81-d9ca2aeca9e6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "RECTAL",
"source": "ndc",
"strength": "30; 10",
"substance": "LIDOCAINE HYDROCHLORIDE; HYDROCORTISONE ACETATE",
"productndc": "13925-163",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/g; mg/g",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about lidocaine hydrochloride; hydrocortisone acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.